Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3145 SEK | +2.11% | +5.89% | +65.70% |
14/05 | Transcript : Acarix AB, Q1 2024 Earnings Call, May 14, 2024 | |
14/05 | Acarix AB Approves Board Elections | CI |
Business Summary
Number of employees: 14
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cardiovascular Diagnostic Method and Associated Equipment
100.0
%
| 6 | 100.0 % | 6 | 100.0 % | +7.20% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
58.4
%
| 2 | 31.2 % | 4 | 58.4 % | +100.27% |
Germany
35.7
%
| 3 | 57.2 % | 2 | 35.7 % | -32.99% |
Sweden
3.0
%
| 0 | 6.8 % | 0 | 3.0 % | -53.05% |
Other
2.4
%
| 0 | 0.2 % | 0 | 2.4 % | +1,577.78% |
Austria
0.5
%
| 0 | 2.6 % | 0 | 0.5 % | -79.22% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 60 | 01/07/01 | |
Director of Finance/CFO | 60 | 01/16/01 | |
Jennifer Matson
CTO | Chief Tech/Sci/R&D Officer | 47 | 01/22/01 |
Chief Operating Officer | 50 | 01/22/01 | |
Tobias Fritz
CTO | Chief Tech/Sci/R&D Officer | 45 | 01/21/01 |
Public Communications Contact | 45 | 01/22/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 51 | 11/21/11 | |
Ulf Rosén
BRD | Director/Board Member | 64 | 01/14/01 |
Director/Board Member | 70 | 11/21/11 | |
Director/Board Member | 59 | 01/20/01 | |
Mikael Thoren
BRD | Director/Board Member | 60 | 01/23/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 737,188,816 | 649,218,759 ( 88.07 %) | 0 | 88.07 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+65.70% | 22.8M | |
-41.90% | 2.95B | |
+19.36% | 1.88B | |
-1.05% | 1.63B | |
+33.96% | 1.34B | |
-16.83% | 959M | |
-21.96% | 888M | |
+7.07% | 842M | |
-26.98% | 623M | |
+10.85% | 513M |
- Stock Market
- Equities
- ACARIX Stock
- Company Acarix AB